Procainamide Hydrochloride
Product Images NDC 71872-7170

Procainamide HCL Injection is a sterile, nonpyrogenic solution used for LM or LV use after dilution. It comes in a 1,000 mg/10 mL (100 mg/mL) 10 mL multiple-dose vial, containing methylparaben NF 1 mg/mL added as preservative, and sodium metabisulfite NF 0.8 mg/mL. It is pH adjusted if necessary using hydrochloric acid or sodium hydroxide, and the usual dosage can be found in the insert. It should not be used if it is darker than a slightly yellow or discolored in any other way. Aseptic technique should be observed, and the stopper should be cleansed with an antiseptic before use. It should be stored at a controlled room temperature of 20°-25°C (68°-77°F). The solution is manufactured for Nexus Pharmaceuticals, INC by Manufacturer NOC 14789.0601-10 and is repackaged and distributed by W l (') scotiscle, AZ 260. WARNING: CONTAINS METABISULFITE.*

NDC 14789-901-10 is a multiple-dose vial containing 1,000mg of Procainamide HCL injection, USP with a concentration of 100mg/mL. It is manufactured by Nexus Pharmaceuticals Inc, Vernon Hills, IL and is available only as a prescription. Each mL contains Procainamide HCI USP 100 mg as the active ingredient, methylparaben NF 1 mg/mL added as a preservative, sodium metabisulfite NF 0.8 mg/mL, and water for injection if necessary adjusting pH value by hydrochloric acid or sodium hydroxide. The manufacturer warns that discolored injections or darker than slightly yellow should not be used as it contains Metabisulfites. It should be stored at 20° to 25°C (68° to 77°F).*